Salon de l’aronautique de Singapour — Nouvelles du programme CSeries avec Rob Dewar – Video

Posted on by


Salon de l #39;aronautique de Singapour -- Nouvelles du programme CSeries avec Rob Dewar
Rob Dewar, Vice-prsident et Directeur Gnral, Programme CSeries, nous fait part du plus rcent statut sur les appareils CSeries. Suivez les nouvelles du pr...

By: Bombardier Aerospace

Visit link:

Salon de l'aronautique de Singapour -- Nouvelles du programme CSeries avec Rob Dewar - Video

Singapore Airshow — Bombardier CSeries – Aircraft Lessor Testimonials – Video

Posted on by


Singapore Airshow -- Bombardier CSeries - Aircraft Lessor Testimonials
The Bombardier Aerospace CSeries family of aircraft now has more than 200 firm orders! Listen to Aircraft Lessors testimonials from the Singapore Airshow. Fo...

By: Bombardier Aerospace

Go here to see the original:

Singapore Airshow -- Bombardier CSeries - Aircraft Lessor Testimonials - Video

How China Fooled the World With Fiat

Posted on by

By Dr. Jeffrey Lewis

The Chinese financial system, along with the rest of the emerging market, exist as an extension of "the world is flat monetary policy" on a scale never seen before. It is equally a giant leverage play on the last remaining resources for a population that has overproduced its stay.

The financial blog Zerohedge.com recently presented a summary of a BBC program featuring a report from Robert Peston, who traveled to China to investigate how the mighty economic giant could actually be in serious trouble.

http://www.bbc.co.uk/programmes/b006mgxx

We've excerpted and commented below...

"China is now the second largest economy in the world and for the last 30 years China's economy has been growing at an astonishing rate, wowing the world, as spending and investment has been undertaken on a scale never seen before in human history - 30 new airports, 26,000 miles of motorways and a new skyscraper every five days have been built in China in the last five years. It is all eerily reminiscent of what happened in the West... the vast majority of it has been built on credit."

Credit equals fiat or currency backed by faith. It is held up by law and force by proxy or by fiat. And while this currency can be created at the will of issuing authorities, it is readily exchangeable and/or replaced by another of the same quality or nature. While exchange rates give rise to the perception of relative value, and massive trade arbitrages the differences, in the end it is all an illusion hanging by a thread of confidence. This confidence, by definition, is unstable and obviously unsustainable.

"This has now left the Chinese economy with huge debts and questions over whether much of the money can ever be paid back (spoiler alert: it can't and it won't)".

Faith is pure emotion. Emotions rise and fall with the tides and the winds of change. It is just a matter of time before the tipping point arrives, driving the masses toward a kind of fiat agnosticism.

"There is an unresolved self-contradiction in Chinas current policies: restarting the furnaces also reignites exponential debt growth, which cannot be sustained for much longer than a couple of years."

Read this article:
How China Fooled the World With Fiat

‘Largest ever’ trial of adult stem cells in heart attack patients begins

Posted on by

Current ratings for: 'Largest ever' trial of adult stem cells in heart attack patients begins

Public / Patient:

5 1 rating

Health Professionals:

0 0 ratings

The largest ever trial of adult stem cell therapy in heart attack patients has begun at The London Chest Hospital in the UK.

Heart disease is the world's leading cause of death. Globally, more than 17 million people died from heart disease last year. In the US, over 1 million people suffer a heart attack each year, and about half of them die.

Heart attacks are usually caused by a clot in the coronary artery, which stops the supply of blood and oxygen to the heart. If the blockage is not treated within a few hours, then it causes the heart muscle to die.

The stem cell trial - titled "The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on allcause mortality in acute myocardial infarction," or "BAMI" for short - has been made possible due to a 5.9 million ($8.1 million) award from the European Commission.

The full study involves 19 partners across France, Germany, Italy, Finland, Denmark, Spain, Belgium, Poland, the Czech Republic and the UK.

Read this article:
'Largest ever' trial of adult stem cells in heart attack patients begins

Heart attack stem cell trial starts

Posted on by

Doctors at a London hospital have started treating heart attack patients with their own stem cells in the largest trial of its kind ever undertaken.

The patients at the London Chest Hospital are among the first of 3000 participants in a Europe-wide study looking at the life-prolonging potential of stem cell therapy.

All will be treated within five days of suffering a heart attack. Stem cells taken from bone marrow will be injected into their hearts in the hope of increasing survival rates by a quarter.

The European Commission has contributed STG4.8 million ($A8.91 million) to the BAMI trial taking place in 10 European countries.

It follows the 'Regenerate' series of three smaller charity-funded studies led by Barts Health NHS Trust consultant cardiologist Professor Anthony Mathur.

'The BAMI study is the biggest and most comprehensive trial of its kind in the world and follows the successful Regenerate trials,' said chief trial co-ordinator Prof Mathur.

'It has taken two years to get to the point where we are ready to accept patients, but we have now reached that stage and we are all very excited.

'Our studies will tell us if adult stem cells from bone marrow can repair damaged hearts and, if so, how these cells should be administered to patients.'

Co-researcher Professor John Martin, from University College London, said: 'This trial brings together a powerful partnership of European doctors and scientists to solve a fundamental problem of importance to all people. It will give an answer about whether adult multi-potential stem cells in their natural environment can treat human disease.'

Stem cells are immature 'mother' cells capable of developing into different tissue types.

Read the original post:
Heart attack stem cell trial starts

Okyanos Heart Institute CEO Matt Feshbach to Speak on Panel at International Stem Cell Society Global Conference

Posted on by

Freeport, The Bahamas (PRWEB) February 21, 2014

Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, announces CEO Matt Feshbach will present at the STEMSO Conference. He will join a panel to discuss the opportunities available through the new stem cell research and Therapy Act. The conference will be held at the Grand Lucayan Resort in Freeport, Grand Bahamas, February 19-22, 2014. The panel discussion will be Friday, February 21 from 8:45 9:45 a.m.

The conference, titled Bridging the Gap: Research to Point of Care, brings together medical scientists, clinicians, regulatory experts, and investors to discuss progress in the field of research and clinical protocols and the process of taking promising therapies to fight chronic disease to market in a responsible manner.

Friday opening remarks will be delivered by Ian Rolle, President of Grand Bahama Port Authority from 8:30 a.m. to 8:45 a.m. followed by the panel presentation until 9:45 a.m. which, in addition to Rolle will include Feshbach, Mitchell Fuerst, Esq., managing partner, Fuerst, Ittleman, David and Joseph. The panel will be moderated by Arthur K. Parris, Jr. of Parris Whittaker.

"With the passing of the Bahamas Stem Cell Research and Therapy Act, which requires high standards of patient safety and care, we believe the Bahamas is an ideal location to bring internationally-approved, adult stem cell technology to patients with unmet medical needs such as chronic coronary artery disease (CAD), says Feshbach. I am pleased to discuss the opportunities available in the Bahamas with investors, doctors and other stakeholders interested in making the Bahamas a world-class destination for adult stem cell therapy."

The STEMSO 2014 Conference in Freeport, Grand Bahama poses a unique opportunity for medical organizations which focus on adult stem cell-based medical treatments, states Douglas Hammond, president of STEMSO. This conference will provide companies looking to expand their research or clinical practices to offshore locations many good reasons to choose the Bahamas. Those attending will be able to network and view the most advanced research and clinical protocols utilizing autologous and allogeneic stem cells in the world today.

The complete agenda can be found on the organizations website at http://www.stemso.org. Other speakers include stem cell researchers, scientists and practitioners from around the world with leading discoveries in the field, and investors in the healthcare space.

Registration is open for attending and exhibiting on STEMSOs website.

ABOUT OKYANOS HEART INSTITUTE: (Oh key AH nos) Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive procedure, can stimulate the growth of new blood vessels, a process known as angiogenesis. Angiogenesis facilitates blood flow in the heart, which supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos, the Greek god of rivers, symbolizes restoration of blood flow. For more information, go to http://www.okyanos.com/.

NEW MEDIA CONTENT: Okyanos LinkedIn Page: http://www.linkedin.com/company/okyanos-heart-institute Okyanos Facebook Page: https://www.facebook.com/OKYANOS Okyanos Twitter Page: https://twitter.com/#!/OkyanosHeart Okyanos Google+ Page: https://plus.google.com/+Okyanos/posts Okyanos You Tube Physician Channel: http://www.youtube.com/user/okyanosforphysicians

See the original post here:
Okyanos Heart Institute CEO Matt Feshbach to Speak on Panel at International Stem Cell Society Global Conference

Fruit Fly Model Organism: How a Developmental Gene Influences Sperm Formation

Posted on by

21.02.2014 - (idw) Ruprecht-Karls-Universitt Heidelberg

Heidelberg researchers have been delving into the basic regulatory mechanisms of stem cell differentiation. Using the Drosophila melanogaster fruit fly as a model organism, the team led by Prof. Dr. Ingrid Lohmann at Heidelberg University's Centre for Organismal Studies was able to show how a special developmental gene from the Hox family influences germline stem cells. These cells are responsible for sperm formation. The scientists found that impairment of Hox gene function resulted in prematurely aged sperms. Press Release Heidelberg, 21 February 2014

Fruit Fly Model Organism: How a Developmental Gene Influences Sperm Formation Heidelberg researchers study basic regulatory mechanisms of stem cell differentiation

Heidelberg researchers have been delving into the basic regulatory mechanisms of stem cell differentiation. Using the Drosophila melanogaster fruit fly as a model organism, the team led by Prof. Dr. Ingrid Lohmann at Heidelberg University's Centre for Organismal Studies was able to show how a special developmental gene from the Hox family influences germline stem cells. These cells are responsible for sperm formation. The scientists, working in the Maintenance and Differentiation of Stem Cells in Development and Disease Collaborative Research Centre (CRC 873), found that impairment of Hox gene function resulted in prematurely aged sperms.

As immature somatic cells, stem cells can mature into different types of cells, thus making them responsible for the development of all the tissues and organs in the body. They are also able to repair damaged adult cells. Advancements in medical research have shown that stem cells can be used to treat certain diseases. To fulfil the promise of stem cell therapy, it is important to discover the function of the respective stem cells and understand how they interact with their environment, that is, the surrounding cells and tissues, explains Prof. Lohmann, who heads the Developmental Biology research group at the Centre for Organismal Studies (COS).

This microenvironment, which stabilises and regulates stem cell activity, is called a stem cell niche. The Heidelberg research team investigated the niches in the testis of the fruit fly. The germline stem cells there produce daughter cells that develop into mature sperms. In our studies, we wanted to find out the nature, if any, of the relationship between germline stem cells and the gene Abd-B, states Prof. Lohmann, who further explains that Abd-B belongs to a family of developmental genes referred to as Hox genes. These Hox genes control the activity of a multitude of other genes that are responsible for the early development of an organism.

In CRC 873, funded by the German Research Foundation, medical and biological scientists investigate the basic regulatory mechanisms that control the self-renewal and differentiation of stem cells. Different model organisms like the fruit fly Drosophila melanogaster are used for their research, aimed at decoding the principles of stem cell control with the aim to also apply them to higher forms of life and eventually humans. The research results of Prof. Lohmann and her team were published in the journal Developmental Cell.

Original publication: F. Papagiannouli, L. Schardt, J. Grajcarek, N. Ha, I. Lohmann: The Hox Gene Abd-B Controls Stem Cell Niche Function in the Drosophila Testis. Developmental Cell, Vol 28. Iss 2, 189-202 (27 January 2014), doi: 10.1016/j.devcel.2013.12.016

Internet information: Research group of Ingrid Lohmann: http://www.cos.uni-heidelberg.de/index.php/i.lohmann?l=_e

Contact: Prof. Dr. Ingrid Lohmann Centre for Organismal Studies Phone: +49 6221 54-51312 ingrid.lohmann@bioquant.uni-heidelberg.de

Read more from the original source:
Fruit Fly Model Organism: How a Developmental Gene Influences Sperm Formation

3-D Printing and Additive Manufacturing: Preview issue of groundbreaking peer-reviewed journal now available

Posted on by

PUBLIC RELEASE DATE:

21-Feb-2014

Contact: Sophie Mohin smohin@liebertpub.com 914-740-2100 x2254 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, February 20, 2014A new era of manufacturing is upon us. Recent developments in 3D printing and additive manufacturing technologies are set to usher in the next generation of industrial competitiveness. To address the rapid advances and potential of this groundbreaking new technology, Mary Ann Liebert, Inc., publishers has released an exclusive preview issue of our new peer-reviewed journal 3D Printing and Additive Manufacturing (3DP).

Editor-in-Chief Dr. Hod Lipson, Director of Cornell University's Creative Machines Lab at the Sibley School of Mechanical and Aerospace Engineering, and his expert Editorial Board invite you to view this exclusive preview issue. The Journal will explore emerging challenges and opportunities in additive manufacturing, ranging from new developments of processes and materials, to novel applications in new areas, such as health, medicine, and bio-printing.

To maximize the global impact of this important forum, the articles will be translated into Mandarin Chinese and appear alongside the English version.

"This powerful new journal provides a much-needed multidisciplinary forum on the rapidly evolving technologies of 3D printing engineering and additive manufacturing on a global scale," says Dr. Lipson. "3DP provides a much-needed professional forum for professionals interested in 3D printing across diverse fields, to work towards establishing the next industrial revolution. This journal provides biologists, engineers, materials specialists, and computer scientists a common meeting place."

3DP also addresses the important questions surrounding this powerful and growing field, including issues in policy and law, intellectual property, data standards, safety and liability, environmental impact, social, economic, and humanitarian implications, and emerging business models at the industrial and consumer scales.

###

Contact: Sophie Mohin, Mary Ann Liebert, Inc., (914) 740-2100, smohin@liebertpub.com

See original here:
3-D Printing and Additive Manufacturing: Preview issue of groundbreaking peer-reviewed journal now available

Progressive Behavioral Science presents Teaching Swimming to Special Needs Children – Video

Posted on by


Progressive Behavioral Science presents Teaching Swimming to Special Needs Children
Miss Samantha of Splashes Smiles talks with Maria Arizmendi of Progressive Behavioral Therapy about teacing swiming to special needs childrens.

By: Progressive Behavioral Science

See the original post here:
Progressive Behavioral Science presents Teaching Swimming to Special Needs Children - Video